Abstract Cytostatic drugs are a troublesome class of emerging pollutants in water owing to their potential effects on DNA. Here we studied the removal of 5-fluorouracil from water using the electro-Fenton process. Galvanostatic electrolyses were performed with an undivided laboratory-scale cell equipped with a boron-doped diamond anode and a carbon felt cathode. Results show that the fastest degradation and almost complete mineralization was obtained at a Fe 2? catalyst concentration of 0.2 mM. The absolute rate constant for oxidation of 5-fluorouracil by hydroxyl radicals was 1.52 9 10 9 M -1 s -1 . Oxalic and acetic acids were initially formed as main short-chain aliphatic by-products, then were completely degraded. After 6 h the final solution mainly contained inorganic ions (NH 4 ? , NO 3 -and F -) and less than 10% of residual organic carbon. Hence, electroFenton constitutes an interesting alternative to degrade biorefractory drugs.
Introduction
Pharmaceuticals are non-regulated trace organic emerging contaminants that are ubiquitous in the aquatic environment due to discharge of effluents from pharmaceutical industry, hospitals and municipal wastewater treatment facilities (Feng et al. 2015; Petrie et al. 2015) . In most cases, these pollutants are also present in the digested sludge, potentially entailing a high ecotoxicological risk (Martín et al. 2012) . In order to avoid the propagation and subsequent accumulation of pharmaceutically active compounds in water bodies, specific prevention systems should be devised at major point sources of pollution. In the case of pharmaceuticals, such locations are hospitals and production sites. Unfortunately, removal efficacy data are scarce since the vast majority of the studies only focus on their impact on pharmaceutical loads.
The most hazardous representatives among these pollutants are those with a very powerful pharmacological action. Among them, the class of cytostatic (antineoplastic) drugs, used to prevent or inhibit the growth of malignant cells or tumors, can display severe negative effects on nontarget organisms including humans, like carcinogenicity, cytotoxicity, genotoxicity, mutagenicity and teratogenicity (Kosjek et al. 2013) . 5-Fluorouracil ( Fig. 1) belongs to the subclass of antimetabolites, and its consumption reaches the range of tonnes in Europe. Several studies have reported its presence in natural water at concentrations ranging from ng L -1 to lg L -1 (Lutterbeck et al. 2016 ). Conventional water treatment methods based on biological processes have been shown as insufficient to eliminate the majority of target pharmaceuticals because of their high recalcitrance and toxicity to bacteria (Kovalova et al. 2012) . 5-Fluorouracil is not an exception, and, furthermore, it has been demonstrated that photodegradation by sun is not suitable for its removal either, showing partial degradation and no mineralization (Lutterbeck et al. 2016) . Therefore, it does not undergo natural attenuation in the environment and cannot be removed in traditional treatment plants. Chemical degradation with NaClO or H 2 O 2 could be an option to face up to this troubling situation, as tested in the hospital environment (Castegnaro et al. 1997) . Alternatively, several enhanced water treatment technologies have been developed in recent years. In particular, the advanced oxidation processes (AOP), which utilize strong reactive oxidant species like hydroxyl radicals ( OH) generated on site, present appealing perspectives for treating biorefractory pollutants (Oturan and Aaron 2014) . A relatively new group of AOP is constituted by electrochemical methods such as electro-oxidation, Fenton-based electrochemical AOP and photoelectrocatalysis, whose great performance during the treatment of pharmaceuticals has been thoroughly reviewed (Sirés and Brillas 2012; Feng et al. 2013; Brillas and Sirés 2015) . The common feature of all the EAOPs is their ability to generate reactive oxygen species (ROS), as either superoxides (MO x ) or hydroxyl radicals (M( OH)), adsorbed on the anode (M) surface from the oxidation of water. Active anodes like Pt promote the formation of the first kind of ROS, whereas non-active anodes like boron-doped diamond (BDD) foster the second type via reaction (1). However, only the Fentonbased electrochemical AOP like electro-Fenton process are able to produce homogeneous OH from Fenton's reaction (2) thanks to the in situ generation of H 2 O 2 from the twoelectron cathodic reduction of O 2 :
The fundamentals and reactivity of electro-Fenton process are well described elsewhere (Brillas et al. 2009 ). Electro-Fenton has been successfully employed for the treatment of acidic aqueous solutions containing antibiotics, antidepressants or b-blockers, among others, using undivided electrolytic cells with different anodes (Sirés et al. 2010; Dirany et al. 2012; Estrada et al. 2012; Panizza et al. 2014; Salazar et al. 2017) . However, there have been no studies dealing with the application of electro-Fenton to the degradation of cytostatic agents. Regarding 5-fluorouracil, only a few publications have reported its treatment by AOP, including photocatalysis with TiO 2 (Lin and Lin 2014) , UV/H 2 O 2 (Lutterbeck et al. 2015) , as well as Fenton and photo-Fenton processes (Governo et al. 2017; Koltsakidou et al. 2017) . In this context, the aim of the present work is to optimize the key operation parameters for a fast drug decay and large mineralization of aqueous solutions of the emerging pollutant 5-fluorouracil by electro-Fenton using a BDD/carbon felt cell, trying to confirm the great oxidation power of this method to treat highly biorecalcitrant molecules.
Experimental
The cytostatic drug 5-fluorouracil was of analytical grade (purity higher than 99%) from Sigma-Aldrich, and it was used as received. Solutions were prepared with ultra-pure water obtained from a Millipore Simplicity 185 water purification system with resistivity higher than 18 MX cm. Iron(II) sulfate heptahydrate used as source of Fe 2? ions (catalyst) and sodium sulfate added as supporting electrolyte were of analytical grade from Acros Organics and Sigma-Aldrich, respectively. Sulfuric acid from Merck was added to adjust initial pH of all solutions. Salts used as standard in ion chromatography were of ACS grade (purity higher than 99.5%) from Sigma-Aldrich. Methanol used as organic solvent for high-performance liquid chromatography (HPLC) was purchased from VWR.
A bench-scale, open, undivided glass cell was used in batch operation mode at room temperature to carry out galvanostatic electrolyses using an HM8040-3 Hameg power supply. The cell was filled with 200 mL of a 0.1 mM drug solution containing 0.05 M Na 2 SO 4 and a given amount of FeSO 4 , at pH 3.0 since it is the optimal value for performing electro-Fenton treatments (Brillas et al. 2009 ). A carbon felt cathode (18.5 cm 9 4.5 cm) from Carbone-Lorraine was placed covering the inner wall of the cell, and a PTFE mesh was used to keep it apart from the anode, a thin film BDD on niobium substrate (6.0 cm 9 4.0 cm) centered in the cell. The solution was saturated with O 2 by sparging compressed air at 1 L min -1 , starting 15 min before electrolysis, and continuous stirring (450 rpm) was maintained during the trials. The experiments were run in triplicate.
Drug decays were monitored by reversed-phase HPLC using a Merck Lachrom chromatograph fitted with a Purospher Star RP-18, 5 lm, 25 cm 9 4.6 mm (i.d.), column at 40°C and coupled with an Elite Lachrom L-2400 UV detector selected at k = 277 nm. Analyses were carried out isocratically by using a 5:95 (v/v) methanol/water mixture, both with 0.1% acetic acid, at 0.4 mL min -1 , employing the EZChrom Elite 3.1 software. In competition kinetics experiments (see Panizza et al. 2014) , the HPLC analysis was made with a 30:70 (v/ v) methanol/water solution (0.1% acetic acid in each) as mobile phase at 0.3 mL min -1 . Short-chain carboxylic acids were determined by ion-exclusion chromatography using the same equipment, with a Supelcogel H, 9 lm, [25 cm 9 4.6 mm (i.d.)] column at room temperature, the detector set at k = 210 nm and using 1% H 2 SO 4 as mobile phase at 0.2 mL min -1 . Inorganic ions were analyzed on a Dionex ICS-1000 chromatograph that included self-regenerating suppressors. The system was equipped with a DS6 conductivity detector containing a cell heated at 35°C. An anion-exchange column (IonPac AS4ASC, 25 cm 9 4 mm) fitted with an IonPac AG4A-SC column guard was used to analyze the anions. For cations (NH 4 ? ), a cation-exchange column (IonPac CS12A, 25 cm 9 4 mm) fitted with an IonPac CG12A column guard was used. A mixture of 1.8 mM Na 2 CO 3 and 1.7 mM NaHCO 3 at 2.0 mL min -1 and a 9.0 mM H 2 SO 4 solution at 1.0 mL min -1 were eluted as mobile phases. The mineralization of each solution was monitored from the total organic carbon (TOC) abatement, using the non-purgeable organic carbon method with ± 2% accuracy, determined on a Shimadzu VCSH analyzer. The average values with an error below 2% are reported in all figures.
Results and discussion
Optimization of electro-Fenton parameters for 5-fluorouracil removal
The catalyst content and applied current (I) are the most crucial operation parameters to be optimized in electroFenton treatments. First, the effect of the initial Fe 2? concentration on 5-fluorouracil destruction was studied at 300 mA. The drug decay with electrolysis time is represented in Fig. 1 as the ratio between the concentrations of pollutant at time t and before the electrolysis. As can be observed, the destruction of the drug was quick and complete in all cases. At 0.1 mM Fe 2? , total disappearance is attained in only 7 min, thanks to the synergistic action of OH formed in the bulk and BDD ( OH) adsorbed on the anode surface (Brillas et al. 2009 ). Afterward, the effect of the applied current for treating acidic 0.1 mM 5-fluorouracil solutions was studied using 0.2 mM Fe 2? . The time-course of normalized drug concentration is shown in Fig. 2 . Again, a fast and total destruction is achieved, being required a shorter time as current increases. For example, the application of currents from 50 to 300 mA allows shortening the required time from 9 to 6 min. This is due to the gradually greater production of BDD( OH) from reaction (1), as well as of OH via reaction (2) due to the upgrading of H 2 O 2 cathodic electrogeneration. In contrast, the application of a higher current like 400 mA is detrimental, since the process becomes slower so as to need 7 min to completely remove the drug. This can also be confirmed from the right panel of Fig. 2 , which informs about the dependence of the percentage of drug removal at 2 min on the applied current. The values of k app ranged between 0.38 and 0.60 min -1 , with a maximum of 0.74 min -1 appearing at 300 mA. As mentioned above, this deceleration can be justified by the larger extent of parasitic reactions, such as the attack of hydroxyl radicals onto the extra H 2 O 2 as well as onto the reaction intermediates (whose formation rate increases as current rises), along with the promotion of the four-electron reduction of O 2 to H 2 O. Analogous dependence of k app on current was found for electro-Fenton treatments with 0.1 and 0.5 mM Fe 2? , although in those cases the k app -range was remarkably lower, from 0.26 to 0.42 and 0.16 to 0.40 min -1 , respectively, confirming the superiority of 0.2 mM Fe 2? . From competition kinetics trials using p-hydroxybenzoic acid as reference (Oturan and Aaron 2014) , the absolute rate constant (k abs ) for the reaction between 5-fluorouracil and hydroxyl radical was determined for the first time, obtaining (1.52 ± 0.01) 9 10 9 M -1 s -1 .
Mineralization of 5-fluorouracil solutions and byproducts generated
The effect of Fe 2? content and current on the mineralization ability of the electro-Fenton process is shown in Fig. 3 as the percentage of TOC removal with time. Figure 3A confirms that 0.2 mM Fe 2? is also the optimal concentration for the degradation of reaction intermediates, since the removal percentage increased from 76 to 86% at 360 min. Further increase of the catalyst content to 0.5 mM was detrimental, with a slower and lower final mineralization of 82%. In order to assess the possibility of attaining larger TOC removals, current was tested from 200 to 1500 mA (Fig. 3B) . As can be seen, almost overall mineralization (higher than 94%) was achieved at the highest current value due to the simultaneous action of hydroxyl radicals onto the parent drug and its intermediates, whereas gradually lower percentages were achieved as the applied current decreased. Depending on the energy cost, currents lower than 1500 mA can be chosen, still attaining more than 90% mineralization at long time.
The attack of OH and BDD( OH) on the cyclic structure causes its hydroxylation upon attack onto nitrogen atoms and/or -CH group (Lutterbeck et al. 2016) , followed by ring cleavage with formation of carboxylic acids. This is demonstrated for 5-fluorouracil in Fig. 4A , where acetic and oxalic acids (as free molecules or complexed with Fe 2? ions) are accumulated since the beginning of the electrolyses and then progressively destroyed, in agreement with the low TOC remaining in the final solutions. The oxidation of the drug is accompanied by the release of heteroatoms. Figure 4A shows that F is almost completely released as F -, whereas nitrogenated ions (NH 4 ? and NO 3 -) only account for less than 60% of the initial N, which can be explained by the formation of N-containing soluble organic matter along with the production of volatile products such as N 2 and N x O y . Fig. 1 . B Effect of applied current as in Fig. 2 , but within a higher range. Mineralization is optimal at 0.2 mM Fe 2? and 1500 mA
Conclusion
The fastest destruction of cytotoxic drug 5-fluorouracil by electro-Fenton process (6 min at 300 mA) was reached at an optimum Fe 2? concentration of 0.2 mM. Regarding the mineralization of 5-fluorouracil solutions, the application of 1500 mA ensured the abatement of more than 94% TOC. The second-order rate constant (k abs ) for oxidizing this drug with hydroxyl radical was determined for the first time. Electro-Fenton process is shown as highly effective for destroying cytostatic pharmaceutical residues in water. 
